AI-generated summary
The authors conducted a meta-analysis of 12 randomized controlled trials with 1,064 patients to assess fractional CO2 laser combined with 308 nm excimer laser for non-segmental vitiligo. They report higher rates of excellent and good re-pigmentation with the combined treatment than with control, and comparable adverse event rates. The authors call for more high-quality, large-scale trials to confirm these results.
- Participants
- 1,064
- Studies included
- 12
- Who or what was studied
- Patients with non-segmental vitiligo
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The authors state that more high-quality, large-scale randomized trials are needed and that long-term efficacy and safety remain to be explored.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 308 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Meta-analysis, Adverse event, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.